- Messages
- 91
- Type of diabetes
- Type 2
- Treatment type
- Diet only
- Dislikes
- No longer being prescribed metformin.
I have been taking an interest in the concept of remission recently... I am about to get my 2nd NHS Hba1C reading much earlier than I'd expected, and I know from recent home testing with an AC1now test kit and Libre that - barring significant measurement error on both - it will be below the UK target remission threshold of 6.5% (albeit this is being artificially helped by 500 mg/day metformin).
However when digging into remission values, I found the following contradicting information from 2009:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768219/
To quote;
Partial remission is sub-diabetic hyperglycemia (A1C not diagnostic of diabetes [<6.5%], fasting glucose 100–125 mg/dl [5.6–6.9 mmol/l]) of at least 1 year's duration in the absence of active pharmacologic therapy or ongoing procedures.
Complete remission is a return to “normal” measures of glucose metabolism (A1C in the normal range, fasting glucose <100 mg/dl [5.6 mmol/l]) of at least 1 year's duration in the absence of active pharmacologic therapy or ongoing procedures.
The threshold for "pre-diabetes" is taken as >5.7%, so remission is taken in the UK as being a return to a pre-diabetic threshold not that of the healthy populace. The question then is, are either of these enough to address health risks and so meaningful as a target. Turns out this has already been looked into by another member, pavlosn:
https://www.diabetes.co.uk/forum/threads/can-hba1c-be-too-low.68973/
The third set of diagrams he pasted shows a morbidity increase for Hba1C which starts to ramp up at around 6%. What I can't find is any clinical data that supports a 6.5 % target as being a meaningful value.
Given above the 5.7% target makes sense to me.
However when digging into remission values, I found the following contradicting information from 2009:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768219/
To quote;
Partial remission is sub-diabetic hyperglycemia (A1C not diagnostic of diabetes [<6.5%], fasting glucose 100–125 mg/dl [5.6–6.9 mmol/l]) of at least 1 year's duration in the absence of active pharmacologic therapy or ongoing procedures.
Complete remission is a return to “normal” measures of glucose metabolism (A1C in the normal range, fasting glucose <100 mg/dl [5.6 mmol/l]) of at least 1 year's duration in the absence of active pharmacologic therapy or ongoing procedures.
The threshold for "pre-diabetes" is taken as >5.7%, so remission is taken in the UK as being a return to a pre-diabetic threshold not that of the healthy populace. The question then is, are either of these enough to address health risks and so meaningful as a target. Turns out this has already been looked into by another member, pavlosn:
https://www.diabetes.co.uk/forum/threads/can-hba1c-be-too-low.68973/
The third set of diagrams he pasted shows a morbidity increase for Hba1C which starts to ramp up at around 6%. What I can't find is any clinical data that supports a 6.5 % target as being a meaningful value.
Given above the 5.7% target makes sense to me.